Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sachin Silva"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-5 (2023)
Abstract Between February 2020 and May 2022, one million Americans have died of COVID-19. To determine the contribution of those deaths to all-cause mortality in terms of life expectancy reductions and the resulting economic welfare losses, we calcul
Externí odkaz:
https://doaj.org/article/39dbb38243994bda927a5ec8970a7a26
Publikováno v:
PLoS Medicine, Vol 19, Iss 12 (2022)
Background Economic losses due to herpes simplex infections in low- and middle-income countries (LMICs) are unknown. We estimated economic and quality-of-life losses due to genital herpes in 2019, in 90 LMICs, and from 2020 to 2030 in 45 countries in
Externí odkaz:
https://doaj.org/article/62fce22c85b94e999b7e21793de50f9e
Autor:
Marco Schäferhoff, Parth Chodavadia, Sebastian Martinez, Kaci Kennedy McDade, Sara Fewer, Sachin Silva, Dean Jamison, Gavin Yamey
Publikováno v:
Health Systems & Reform, Vol 5, Iss 4, Pp 350-365 (2019)
West Africa’s Ebola epidemic of 2014–2016 exposed, among other problems, the under-funding of transnational global health activities known as global common goods for health (CGH), global functions such as pandemic preparedness and research and de
Externí odkaz:
https://doaj.org/article/21d31bb1c60549fa993deb560b5ee841
Publikováno v:
BMJ Global Health, Vol 6, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/d9656ff856ca43f1aa06804678d9caad
Autor:
Nichola R. Naylor, Rifat Atun, Nina Zhu, Kavian Kulasabanathan, Sachin Silva, Anuja Chatterjee, Gwenan M. Knight, Julie V. Robotham
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 7, Iss 1, Pp 1-17 (2018)
Abstract Background Accurate estimates of the burden of antimicrobial resistance (AMR) are needed to establish the magnitude of this global threat in terms of both health and cost, and to paramaterise cost-effectiveness evaluations of interventions a
Externí odkaz:
https://doaj.org/article/a6ff06cf6ef945b9b9843249f83ff970
Autor:
Nichola R. Naylor, Sachin Silva, Kavian Kulasabanathan, Rifat Atun, Nina Zhu, Gwenan M. Knight, Julie Robotham
Publikováno v:
Systematic Reviews, Vol 5, Iss 1, Pp 1-5 (2016)
Abstract Background Estimates of the burden of antimicrobial resistance (AMR) are needed to ascertain AMR impact, to evaluate interventions, and to allocate resources efficiently. Recent studies have estimated health, cost, and economic burden relati
Externí odkaz:
https://doaj.org/article/3115ee170e8748f1aa959bc9010e1ad8
Publikováno v:
The Lancet Global Health, Vol 5, Iss 7, Pp e720-e726 (2017)
Development assistance for health (DAH), the value of which peaked in 2013 and fell in 2015, is unlikely to rise substantially in the near future, increasing reliance on domestic and innovative financing sources to sustain health programmes in low-in
Externí odkaz:
https://doaj.org/article/937445ed11674d6b960e6beb14650756
Publikováno v:
Journal of Global Health, Vol 6, Iss 1 (2016)
In 2015 around 15 million people living with HIV were receiving antiretroviral treatment (ART) in sub–Saharan Africa. Sustained provision of ART, though both prudent and necessary, creates substantial long–term fiscal obligations for countries af
Externí odkaz:
https://doaj.org/article/ec26c9d935494290aaad0f46d5a02fd5
Assessing the impact of one million COVID-19 Deaths in America – Economic and Life Expectancy Losses
Between February 2020 and May 2022, one million Americans have died of COVID-19. To determine the contribution of those deaths to all-cause mortality in terms of life expectancy reductions and the resulting economic welfare losses, we calculated thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee40b532bf9111c015123d633e6b0ca
https://doi.org/10.21203/rs.3.rs-1855685/v1
https://doi.org/10.21203/rs.3.rs-1855685/v1
Publikováno v:
The Lancet. Global health, vol 9, iss 10
The Lancet. Global Health
The Lancet. Global Health
Summary Background The tuberculosis targets for the UN Sustainable Development Goals (SDGs) call for a 90% reduction in tuberculosis deaths by 2030, compared with 2015, but meeting this target now seems highly improbable. To assess the economic impac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f73f60a8e2cced6d285fea79fa93a0ac
https://escholarship.org/uc/item/2f54t7mz
https://escholarship.org/uc/item/2f54t7mz